The Fabric team will be at #ESHG2024 taking place in Berlin, June 1-4. We're delighted to have partnered with Oxford Nanopore Technologies to pair long-read ultra-rapid whole genome sequencing with AI based interpretation for the NICU. The end-to-end workflow, from sample to answer with push-button integration between Fabric Genomics and Oxford Nanopore, will offer a simple solution for interpreting nanopore’s data-rich, any-length reads by integrating Oxford Nanopore EPI2ME™ software with Fabric’s software-as-a-service platform to provide analysis and clinical reporting. Connect with Michael Vishnevetsky, PhD, our SVP of Business Development & Commercial Operations, or find us at Oxford Nanopore's booth #310, to learn more! #NICU #wholegenomesequencing #WGS
Fabric Genomics
Biotechnology Research
Oakland, California 4,448 followers
AI‑Driven Clinical Insights for Genomic Data
About us
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.
- Website
-
https://www.fabricgenomics.com/
External link for Fabric Genomics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Oakland, California
- Type
- Privately Held
- Founded
- 2009
- Specialties
- variant analysis, genomic interpretation, clinical reporting, and variant calling
Locations
-
Primary
436 14th St
Suite 1300
Oakland, California 94612, US
Employees at Fabric Genomics
Updates
-
We've wrapped up a very successful #LondonCalling event hosted by Oxford Nanopore Technologies! A huge thank you to ONT and their CEO Gordon Sanghera for supporting our collaboration. The event offered a wonderful opportunity to connect and explore the promising future of long read clinical genomics together with a wide variety of partners. A special thank you also to everyone who stopped by our virtual booth to learn about Fabric Genomics and how our interpretation and clinical reporting capabilities, combined with ONT's long-read sequencing technology, are enabling greater access to #WholeGenomeSequencing for pediatric and neonatal healthcare communities. #precisionmedicine
Thank you Gordon Sanghera for highlighting Fabric Genomics as one of the key partners! Looking forward to making a difference together! #nanoporeconf #WholeGenomeSequencing #genomics #RapidPrecisionMedicine
-
We'll be participating in London Calling 2024 this week and are eager to explore the latest innovations in long-read sequencing! Visit us at our virtual booth in the Partners Exhibit Hall to connect and learn more about our cutting-edge solutions for long-read rapid whole genome sequencing. See you there! #WYMM
What you're missing matters! #WYMM. So don't miss London Calling 2024. Hear how you can generate ultra-rich data for answers with real impact. Register to join us online (for free) to see what all the fuss is about. Register here: https://bit.ly/4dB87x9 #nanoporeconf
-
Fabric Genomics reposted this
Amazing work by our Utah collaborators!
We are at an inflection point in the field of precision/genomic medicine, whereby clinical rapid genome sequencing is starting to take root, but not yet fully embraced by most healthcare payors. While the diagnostic utility of clinical genome sequencing in critically ill children is well-recognized, the impact of genomics on clinical outcomes is less established. In this pre-print, we used artificial intelligence (AI) technologies to explore the predictive value of genome sequencing in forecasting clinical outcomes following surgery for congenital heart defects (CHD) in a cohort of 2,253 CHD patients from the Pediatric Cardiac Genomics Consortium (PCGC). The NHBLI-funded PCGC is one of the world’s largest collections of genetic, phenotypic, and clinical variables for CHD and thus provides an excellent resource for exploring the utility of genomics data for outcomes prediction. Our findings define a critical role for genome sequencing in outcomes prediction for congenital cardiac surgeries, especially in the context of higher risk surgical procedures, specific CHD phenotypes and extra-cardiac anomalies. Importantly, the absence of damaging genotypes was protective for adverse outcomes following congenital cardiac surgery. Thus, genomic information is informative whether or not a proband has an identified damaging genotype. Our findings suggest that genome sequencing of all newborns with complex CHD is clinically indicated to empower personalized risk-stratification for outcomes following congenital cardiac surgery. https://lnkd.in/gEZXJu3h
-
Fabric will be attending #CCG2024 in Baltimore. We hope to see you there in person or virtually.
Curating the Clinical Genome is introducing Lightning Talks at #CCG2024! Three rounds of Lightning Talks, with speakers selected from submitted abstracts, will occur during the conference. Each round will have 4-5 speakers who will have 5 minutes each to deliver their talk. No time will be allotted for questions between speakers. See the Lightning Talk speakers and talk titles in the conference program: https://lnkd.in/gHvBM7sU
-
We are excited to share this preprint! Our collaboration with the Pediatric Cardiac Genomics Consortium (PCGC) utilized Fabric GEM AI-based identification of candidate disease-causing genotypes to analyze whole exome sequencing (WES) data for a cohort of 2,253 children affected by congenital heart defects (CHD). CHD, a life-threatening condition, impacts over 40,000 newborns annually in the U.S. Using Fabric GEM AI, the consortium pinpointed damaging genotypes associated with higher risks of mortality, cardiac arrest, and prolonged mechanical ventilation. Additionally, the absence of these variants indicated reduced risk. This work empowers informed decisions, enhancing care and treatment strategies. It’s yet another testament to how cutting-edge clinical researchers leverage Fabric Genomics to advance personalized medicine. https://bit.ly/3JWA5pa #Genomics #PrecisionMedicine #WES
-
Thanks for another great conference Rady Children's Institute for Genomic Medicine! We are proud to partner with you and are looking forward to next year. #GenomicsFrontiers24
What a captivating start to Day 2 at #GenomicsFrontiers24! 🐚 Our Clinical Laboratory Director Lucia Guidugli, Ph.D., FACMG, and Clinical Molecular Geneticist Jennifer Schleit PhD FACMG, began the morning with insights on identifying trinucleotide repeat expansions in DMPK using #rapidWholeGenomeSequencing (rWGS). 🐚 A lightning talk with Whitney Thompson M.D. M.Phil and Eric Klee from Mayo Clinic showcased clever acronyms while discussing challenges and opportunities in clinical urWGS #diagnostics and #therapeutics, and the exciting potential of integrating translational research into urWGS programs. 🐚 Matthew Bainbridge, our Associate Director of Clinical Genomics Research, delivered an enlightening talk on DNA methylation, imprinting, and long-read sequencing, exploring novel approaches to identifying new imprinted regions. 🐚 Dr. Gail Knight, SVP & Chief Medical Officer from Rady Children's Hospital-San Diego, shared moving stories from her upbringing and highlighted how #rWGS has touched her personally and has influenced RCHSD’s use of #genomics in the NICU and PICU. 🐚 We wrapped up the morning with a clinical panel discussion featuring Paige Hazelton from Mayo Clinic, Joseph Fakhoury from Bronson Children's Hospital, Sabrina Jenkins, MD, from University of Utah Health, and Kristen Suhrie from Riley Children's Health, sharing their experiences in the NICU. Stay tuned for a recap of our afternoon sessions!
-
+1
-
Fabric will be at the Executive War College! Please join us tomorrow for this exciting panel presentation on the current state of the genetic testing market. Michael Vishnevetsky, our SVP of Business Development, and fellow industry experts will share valuable strategies and perspectives on navigating the evolving genetic laboratory landscape for enhanced business success. We hope to see you in New Orleans! #FabricGenomics #ExecutiveWarCollege #GeneticLaboratories
-
Looking forward to another great year of Rady Children's Institute for Genomic Medicine's Frontiers in Pediatric Genomic Medicine conference. Please stop by our table to learn how Fabric can assist you in your pediatric genomics program.
👩⚕️Calling all physicians and nurses!👨⚕️ ⬆️ Elevate your expertise at our upcoming Frontiers in Pediatric Genomic Medicine conference on May 1-2. 📚 Earn valuable CME credit from UC San Diego Continuing Professional Development or accrue up to 10.0 continuing education contact hours for nurses. The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California San Diego School of Medicine designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 🌊 Ride the wave of pediatric genomic medicine and discover firsthand how rapid precision medicine is reshaping lives. Don't miss this opportunity to stay ahead in your field! Register for virtual attendance here: https://lnkd.in/gjdBefMc #GenomicsFrontiers24 #CME #pediatrics #WholeGenomeSequencing #genomics #raredisease
-
We are happy to announce that Fabric Genomics has joined Oxford Nanopore Technologies Compatible Products Programme! By pairing Fabric's interpretation and clinical reporting capabilities with ONT's long-read sequencing technology, we're enabling greater access to #WholeGenomeSequencing for pediatric and neonatal healthcare communities.
We are excited to announce the launch of the Compatible Products Programme. The new initiative is designed to showcase and expand the network of approved third-party products to foster a more accessible genomics ecosystem and new applications of nanopore technology. Read here: https://bit.ly/4d9QtA9
Oxford Nanopore Technologies launches Compatible Products Programme to enhance genomic sequencing ecosystem
nanoporetech.com